PHARMACISTS in northern Sydney involved in the Bridging the Gap between Physical and Mental Illness in Community Pharmacy (PharMIbridge) Randomised Control Trial (RCT) commenced training today.
The trial, which was funded through the Sixth Community Pharmacy Agreement aims to enhance the way community pharmacists support people living with severe and persistent mental illness.
The PharMIbridge intervention involves an in-depth medicine support service delivered over six-months and aims to identify and address problems related to psychotropic medication use or physical and psychological health concerns.
The above article was sent to subscribers in Pharmacy Daily's issue from 24 Feb 21
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 24 Feb 21
